Corrigendum to: Hepatitis C Seroprevalence Among Consecutive Labor and Delivery Admissions in Two New York City Hospital...
...Published in Open Forum Infectious Diseases
Corrigendum to: A Major Regional Measles Outbreak: Description of Hospitalized Cases in 2017–2018 at Bordeaux University...
...Published in Open Forum Infectious Diseases
Erratum to: Clinical Features and Outcomes of Community-Acquired Pneumonia Caused by Haemophilus influenzae
Published in Open Forum Infectious Diseases
Efficacy of Omadacycline Versus Moxifloxacin in the Treatment of Community-Acquired Bacterial Pneumonia by Disease Sever...
Published in Open forum infectious diseases
Severity/mortality risk scores and disease characteristics may assist in deciding whether patients with community-acquired bacterial pneumonia (CABP) require outpatient treatment or hospitalization. The phase 3 OPTIC (Omadacycline for Pneumonia Treatment In the Community) study enrolled patients with Pneumonia Outcomes Research Team (PORT) risk cla...
Clinical Efficacy of Patients With Secondary Bacteremia Treated With Omadacycline: Results From Phase 3 Acute Bacterial ...
Published in Open forum infectious diseases
In this post hoc analysis of the 63 patients with secondary bacteremia enrolled in the 3 omadacycline phase 3 studies of acute bacterial skin/skin structure infections (ABSSSI) and community-acquired bacterial pneumonia (CABP), we determined that omadacycline is a viable therapeutic option for appropriate patients with secondary bacteremia. © The A...
Implementation of an Infectious Diseases Telehealth Consultation and Antibiotic Stewardship Program for 16 Small Communi...
Published in Open Forum Infectious Diseases
An integrated infectious diseases (ID) telehealth service increased access to ID and stewardship expertise for 16 community hospitals, leading to improvements in antibiotic use. Additional studies are needed to determine the optimal ID telehealth consultation type and impact on outcomes.
BNT162b2 Vaccine Effectiveness in Preventing Asymptomatic Infection With SARS-CoV-2 Virus: A Nationwide Historical Cohor...
Published in Open Forum Infectious Diseases
The effectiveness of BNT162b2 vaccine in prevention of asymptomatic infection is unclear. Among individuals who were repeatedly tested for SARS-CoV-2 infection by PCR, we found that the estimated vaccine effectiveness against SARS-CoV-2 virus after two vaccine doses was 89%.
Case Report: Emergent Resistance in a Treatment-Naive Person With Human Immunodeficiency Virus Under Bictegravir-Based T...
Published in Open Forum Infectious Diseases
Few instances of treatment-emergent resistance to bictegravir have been reported in the literature. We describe a case of treatment-emergent resistance to bictegravir in a person recently diagnosed with human immunodeficiency virus who developed M184V and R263K mutations while on therapy.
Persistent SARS-CoV-2 Infection in Immunocompromised Host Displaying Treatment Induced Viral Evolution
...Published in Open Forum Infectious Diseases
We report a COVID-19 case with SARS-CoV-2 persisting beyond 333 days in an immunocompromised patient with chronic lymphocytic leukemia, asymptomatically carrying infectious SARS-CoV-2 at day 197 post diagnosis. Additionally, viral sequencing indicates major changes in the spike protein over time, temporally associated with convalescent plasma treat...
Comparative Analysis of Emerging B.1.1.7+E484K SARS-CoV-2 isolates
...Published in Open Forum Infectious Diseases
We report the genome of a B.1.1.7+E484K SARS-CoV-2 from southeastern Pennsylvania and compare to all high-coverage B.1.1.7+E484K genomes (n=235) available. Analyses showed the existence of at least 4 distinct clades of this variant circulating in the US, and the possibility of at least 59 independent acquisitions of the E484K mutation.
